Business Description
bioAffinity Technologies Inc
NAICS : 541380
SIC : 2835
ISIN : US09076W1099
Description
bioAffinity Technologies Inc addresses the need for noninvasive diagnosis of early-stage cancer and diseases of the lung and targeted cancer treatment. It develops proprietary noninvasive diagnostic tests and cancer therapeutics using technology that preferentially targets cancer cells and cell populations indicative of a diseased state. The company's product, CyPath Lung, is a noninvasive test for the detection of early-stage lung cancer.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.44 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.55 | |||||
| Debt-to-EBITDA | -0.22 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -12.33 | |||||
| Beneish M-Score | 21.66 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 29.7 | |||||
| 3-Year EPS without NRI Growth Rate | 30.1 | |||||
| 3-Year FCF Growth Rate | 5.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 20.26 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 69.33 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 7.32 | |||||
| 9-Day RSI | 16.14 | |||||
| 14-Day RSI | 22.98 | |||||
| 3-1 Month Momentum % | -35.44 | |||||
| 6-1 Month Momentum % | -48.91 | |||||
| 12-1 Month Momentum % | -66.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.02 | |||||
| Quick Ratio | 1.01 | |||||
| Cash Ratio | 0.3 | |||||
| Days Inventory | 1.1 | |||||
| Days Sales Outstanding | 46.27 | |||||
| Days Payable | 41.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -51 | |||||
| Shareholder Yield % | -44.22 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 35.03 | |||||
| Operating Margin % | -89.13 | |||||
| Net Margin % | -90.17 | |||||
| FCF Margin % | -77.59 | |||||
| ROE % | -178.49 | |||||
| ROA % | -106.46 | |||||
| ROIC % | -155.94 | |||||
| 3-Year ROIIC % | 118.29 | |||||
| ROC (Joel Greenblatt) % | -422.33 | |||||
| ROCE % | -144.45 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 0.47 | |||||
| PB Ratio | 1.78 | |||||
| Price-to-Tangible-Book | 5.86 | |||||
| EV-to-EBIT | -0.98 | |||||
| EV-to-EBITDA | -1.05 | |||||
| EV-to-Revenue | 0.87 | |||||
| EV-to-FCF | -1.12 | |||||
| Earnings Yield (Greenblatt) % | -102.04 | |||||
| FCF Yield % | -113.79 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:BIAF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
bioAffinity Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 9.367 | ||
| EPS (TTM) ($) | -0.81 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 82.71 | ||
| 14-Day RSI | 22.98 | ||
| 14-Day ATR ($) | 0.088271 | ||
| 20-Day SMA ($) | 0.728306 | ||
| 12-1 Month Momentum % | -66.18 | ||
| 52-Week Range ($) | 0.3926 - 3.62 | ||
| Shares Outstanding (Mil) | 15.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
bioAffinity Technologies Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
bioAffinity Technologies Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
bioAffinity Technologies Inc Frequently Asked Questions
What is bioAffinity Technologies Inc(BIAF)'s stock price today?
The current price of BIAF is $0.41. The 52 week high of BIAF is $3.62 and 52 week low is $0.39.
When is next earnings date of bioAffinity Technologies Inc(BIAF)?
The next earnings date of bioAffinity Technologies Inc(BIAF) is .
Does bioAffinity Technologies Inc(BIAF) pay dividends? If so, how much?
bioAffinity Technologies Inc(BIAF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers